165 related articles for article (PubMed ID: 21725493)
21. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro.
Ghoneum MH; Ogura T; Gimzewski JK; Ghoneum AD; Henary MC; Agrawal S
Int J Immunopathol Pharmacol; 2018; 32():2058738418797768. PubMed ID: 30270704
[TBL] [Abstract][Full Text] [Related]
22. Isoflavones, genistein and daidzein, regulate mucosal immune response by suppressing dendritic cell function.
Wei J; Bhatt S; Chang LM; Sampson HA; Masilamani M
PLoS One; 2012; 7(10):e47979. PubMed ID: 23110148
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells.
Cools N; Van Tendeloo VF; Smits EL; Lenjou M; Nijs G; Van Bockstaele DR; Berneman ZN; Ponsaerts P
J Cell Mol Med; 2008 Apr; 12(2):690-700. PubMed ID: 18419605
[TBL] [Abstract][Full Text] [Related]
24. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression.
Bernhard H; Huseby ES; Hand SL; Lohmann M; Batten WY; Disis ML; Gralow JR; Meyer zum Büschenfelde KH; Ohlén C; Cheever MA
Immunobiology; 2000 Apr; 201(5):568-82. PubMed ID: 10834314
[TBL] [Abstract][Full Text] [Related]
27. Induction of tolerance by IL-10-treated dendritic cells.
Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
[TBL] [Abstract][Full Text] [Related]
28. IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals.
Torres-Aguilar H; Sánchez-Torres C; Jara LJ; Blank M; Shoenfeld Y
J Clin Immunol; 2010 Sep; 30(5):659-68. PubMed ID: 20544263
[TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-β1-mediated generation of regulatory T cells at late phase.
Kim G; Jang MS; Son YM; Seo MJ; Ji SY; Han SH; Jung ID; Park YM; Jung HJ; Yun CH
PLoS One; 2013; 8(4):e62300. PubMed ID: 23658623
[TBL] [Abstract][Full Text] [Related]
30. Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells.
Kawamura T; Gatanaga H; Borris DL; Connors M; Mitsuya H; Blauvelt A
J Immunol; 2003 Apr; 170(8):4260-6. PubMed ID: 12682260
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
32. Impact of valproic acid on dendritic cells function.
Frikeche J; Simon T; Brissot E; Grégoire M; Gaugler B; Mohty M
Immunobiology; 2012 Jul; 217(7):704-10. PubMed ID: 22209114
[TBL] [Abstract][Full Text] [Related]
33. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.
Perez N; Karumuthil-Melethil S; Li R; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2008 May; 180(10):6566-76. PubMed ID: 18453575
[TBL] [Abstract][Full Text] [Related]
34. The mucosal factors retinoic acid and TGF-β1 induce phenotypically and functionally distinct dendritic cell types.
den Hartog G; van Altena C; Savelkoul HF; van Neerven RJ
Int Arch Allergy Immunol; 2013; 162(3):225-36. PubMed ID: 24022014
[TBL] [Abstract][Full Text] [Related]
35. Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.
Elluru SR; Duong van Huyen JP; Delignat S; Kazatchkine MD; Friboulet A; Kaveri SV; Bayry J
BMC Cancer; 2008 Jun; 8():161. PubMed ID: 18533025
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4+ T cells.
Xiao BG; Huang YM; Xu LY; Ishikawa M; Link H
J Neuroimmunol; 1999 Jun; 97(1-2):25-36. PubMed ID: 10408975
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression.
Mou HB; Lin MF; Cen H; Yu J; Meng XJ
J Zhejiang Univ Sci; 2004 Oct; 5(10):1239-44. PubMed ID: 15362195
[TBL] [Abstract][Full Text] [Related]
38. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
39. Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors.
Matthews NC; Power UF; Reen DJ
Int Immunol; 2007 Jun; 19(6):703-12. PubMed ID: 17493958
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
